Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2022 Filed Nov 10, 2022 16:05 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 3,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-056365 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,874 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2022 Filed Oct 17, 2022 16:35 UTC |
Bujarski Robert JosephPresident & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053823 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170 Underlying: Common Stock · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 389 shares vested on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. F4 · derivative.expiration_date: 389 shares vested on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. Read SEC document |
| October 15, 2022 Filed Oct 17, 2022 16:35 UTC |
Bujarski Robert JosephPresident & COO
|
Tax withholdingCommon Stock | 205 | $76.29 | $15,639.45 |
DisclosureSEC source: 0001209191-22-053823 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,496 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2022 Filed Oct 17, 2022 16:35 UTC |
Bujarski Robert JosephPresident & COO
|
GrantCommon Stock | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053823 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,701 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| October 15, 2022 Filed Oct 17, 2022 16:33 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053824 · doc4.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,170 Underlying: Common Stock · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 389 shares vested on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. F4 · derivative.expiration_date: 389 shares vested on October 15, 2022; the remaining 1,170 shares will vest in equal installments on October 15, 2023, October 15, 2024 and October 15, 2025. Read SEC document |
| October 15, 2022 Filed Oct 17, 2022 16:33 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 193 | $76.29 | $14,723.97 |
DisclosureSEC source: 0001209191-22-053824 · doc4.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| October 15, 2022 Filed Oct 17, 2022 16:33 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-053824 · doc4.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:39 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051851 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137 Underlying: Common Stock · 69 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: 69 shares vested on September 30, 2022; of the remaining 137 shares, 69 shares will vest on December 31, 2022, and 68 shares will vest on March 31, 2023. F3 · derivative.expiration_date: 69 shares vested on September 30, 2022; of the remaining 137 shares, 69 shares will vest on December 31, 2022, and 68 shares will vest on March 31, 2023. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:39 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-051851 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 16:05 UTC |
Bujarski Robert JosephPresident & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050287 · doc4.xml · derivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 628 Underlying: Common Stock · 313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 313 shares vested on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024. F4 · derivative.expiration_date: 313 shares vested on September 14, 2022; the remaining 628 shares will vest in equal installments on September 14, 2023 and September 14, 2024. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 16:05 UTC |
Bujarski Robert JosephPresident & COO
|
Tax withholdingCommon Stock | 165 | $83.25 | $13,736.25 |
DisclosureSEC source: 0001209191-22-050287 · doc4.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,312 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 16:05 UTC |
Bujarski Robert JosephPresident & COO
|
GrantCommon Stock | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050287 · doc4.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,477 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 16:05 UTC |
BRYANT DOUGLAS CDirector · Chairman & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047699 · doc4.xml · derivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,461 Underlying: Common Stock · 1,460 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,460 shares vested on August 24, 2022 and 1,461 shares will vest on August 24, 2023. F4 · derivative.expiration_date: 1,460 shares vested on August 24, 2022 and 1,461 shares will vest on August 24, 2023. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 16:05 UTC |
BRYANT DOUGLAS CDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 724 | $85.80 | $62,119.20 |
DisclosureSEC source: 0001209191-22-047699 · doc4.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506,662 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| August 24, 2022 Filed Aug 26, 2022 16:05 UTC |
BRYANT DOUGLAS CDirector · Chairman & CEO
|
GrantCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047699 · doc4.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,386 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| August 22, 2022 Filed Aug 29, 2022 20:30 UTC |
BRYANT DOUGLAS CDirector · Chairman & CEO
|
GrantRestricted Stock Units (Premium) · Derivative | 3,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047932 · doc4.xml · derivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,140 Underlying: Common Stock · 3,140 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on August 22, 2023. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on August 22, 2023. Read SEC document |
| August 22, 2022 Filed Aug 29, 2022 20:30 UTC |
BRYANT DOUGLAS CDirector · Chairman & CEO
|
GrantRestricted Stock Units (Converted) · Derivative | 10,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047932 · doc4.xml · derivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,222 Underlying: Common Stock · 10,222 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.exercise_date: The restricted stock units vested on August 22, 2022. F2 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. F3 · derivative.expiration_date: The restricted stock units vested on August 22, 2022. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 19:16 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043761 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,340 Underlying: Common Stock · 1,170 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,170 shares vested on 7/28/2022 and 2,340 shares will vest in equal installments on July 28, 2023 and July 28, 2024. F4 · derivative.expiration_date: 1,170 shares vested on 7/28/2022 and 2,340 shares will vest in equal installments on July 28, 2023 and July 28, 2024. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 19:16 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 581 | $102.37 | $59,476.97 |
DisclosureSEC source: 0001209191-22-043761 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,846 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 19:16 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 1,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-043761 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,427 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:52 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041283 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 981 Underlying: Common Stock · 981 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 981 shares vested on July 1, 2022 and 981 shares will vest on July 1, 2023. F4 · derivative.expiration_date: 981 shares vested on July 1, 2022 and 981 shares will vest on July 1, 2023. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:52 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 486 | $97.11 | $47,195.46 |
DisclosureSEC source: 0001209191-22-041283 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,257 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 17:52 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041283 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,743 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 20:15 UTC |
Dilsaver Evelyn SDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040216 · doc4.xml · derivative · entry 2 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206 Underlying: Common Stock · 69 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: 207 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 68 shares will vest on March 31, 2023. F3 · derivative.expiration_date: 207 shares will vest in equal installments on June 30, 2022, September 30, 2022 and December 31, 2022; the remaining 68 shares will vest on March 31, 2023. Read SEC document |
| June 30, 2022 Filed Jul 1, 2022 20:15 UTC |
Dilsaver Evelyn SDirector
|
GrantCommon Stock | 69 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-040216 · doc4.xml · nonDerivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:21 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035182 · doc4.xml · derivative · entry 3 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273 Underlying: Common Stock · 273 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:21 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035182 · doc4.xml · derivative · entry 2 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910 Underlying: Common Stock · 910 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, June 6, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, June 6, 2022. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:21 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035182 · doc4.xml · derivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:20 UTC |
Smith Christopher MDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035179 · doc4.xml · derivative · entry 1 Smith Christopher M · CIK 0001436707 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:17 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 497 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035174 · doc4.xml · derivative · entry 3 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497 Underlying: Common Stock · 497 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:17 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 1,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035174 · doc4.xml · derivative · entry 2 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,659 Underlying: Common Stock · 1,659 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, June 6, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, June 6, 2022. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:17 UTC |
BUECHLER KENNETH FDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035174 · doc4.xml · derivative · entry 1 BUECHLER KENNETH F · CIK 0001238916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035177 · doc4.xml · derivative · entry 3 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224 Underlying: Common Stock · 224 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035177 · doc4.xml · derivative · entry 2 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749 Underlying: Common Stock · 749 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, June 6, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, June 6, 2022. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC |
POLAN MARY LAKE PH DDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035177 · doc4.xml · derivative · entry 1 POLAN MARY LAKE PH D · CIK 0001187716 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Premium) · Derivative | 203 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035178 · doc4.xml · derivative · entry 3 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203 Underlying: Common Stock · 203 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Converted) · Derivative | 1,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035178 · doc4.xml · derivative · entry 2 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,017 Underlying: Common Stock · 1,017 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, June 6, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, June 6, 2022. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:19 UTC |
RHOADS ANN DDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035178 · doc4.xml · derivative · entry 1 RHOADS ANN D · CIK 0001250252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:20 UTC |
Strobeck MatthewDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035180 · doc4.xml · derivative · entry 1 Strobeck Matthew · CIK 0001377832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:18 UTC |
Dilsaver Evelyn SDirector
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035175 · doc4.xml · derivative · entry 1 Dilsaver Evelyn S · CIK 0001391387 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:18 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Premium) · Derivative | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035176 · doc4.xml · derivative · entry 3 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289 Underlying: Common Stock · 289 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:18 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Converted) · Derivative | 963 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035176 · doc4.xml · derivative · entry 2 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 963 Underlying: Common Stock · 963 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F3 · derivative.exercise_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.exercise_date: The restricted stock units vest on the date of the grant, June 6, 2022. F3 · derivative.expiration_date: The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. F4 · derivative.expiration_date: The restricted stock units vest on the date of the grant, June 6, 2022. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:18 UTC |
Michael Edward L.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035176 · doc4.xml · derivative · entry 1 Michael Edward L. · CIK 0001391823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 22:22 UTC |
Wilkins Joseph D Jr.Director
|
GrantRestricted Stock Units (Equity Grant) · Derivative | 2,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035185 · doc4.xml · derivative · entry 1 Wilkins Joseph D Jr. · CIK 0001848760 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248 Underlying: Common Stock · 2,248 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest on June 6, 2023. F2 · derivative.expiration_date: The restricted stock units vest on June 6, 2023. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:13 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantRestricted Stock Units · Derivative | 16,174 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034205 · doc4.xml · derivative · entry 2 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,174 Underlying: Common Stock · 16,174 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F3 · derivative.exercise_date: 5,391 shares will vest on 6/1/2023, 5,391 shares will vest on 6/1/2024 and 5,392 shares will vest on 6/1/2025. F3 · derivative.expiration_date: 5,391 shares will vest on 6/1/2023, 5,391 shares will vest on 6/1/2024 and 5,392 shares will vest on 6/1/2025. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:13 UTC |
Busky Joseph M.Chief Financial Officer
|
GrantNon-Qualified Stock Option · Derivative | 10,411 | $0.00 Strike: $92.74 | $0.00 |
DisclosureSEC source: 0001209191-22-034205 · doc4.xml · derivative · entry 1 Busky Joseph M · CIK 0001385091 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,411 Underlying: Common Stock · 10,411 shares Expires 2032-06-01 F1 · derivative.exercise_date: 3,470 shares will vest on 6/1/2023, 3,470 shares will vest on 6/1/2024 and 3,471 shares will vest on 6/1/2025. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:14 UTC |
Iskra Michael S.Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 10,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034206 · doc4.xml · derivative · entry 2 Iskra Michael S. · CIK 0001839432 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,782 Underlying: Common Stock · 10,782 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F1 · derivative.exercise_date: One-third of the shares will vest annually over a three-year period, commencing on the first anniversary date of the grant. F1 · derivative.expiration_date: One-third of the shares will vest annually over a three-year period, commencing on the first anniversary date of the grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 17:14 UTC |
Iskra Michael S.Chief Commercial Officer
|
GrantNon-Qualified Stock Option · Derivative | 20,823 | $0.00 Strike: $92.74 | $0.00 |
DisclosureSEC source: 0001209191-22-034206 · doc4.xml · derivative · entry 1 Iskra Michael S. · CIK 0001839432 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,823 Underlying: Common Stock · 20,823 shares Expires 2032-06-01 F1 · derivative.exercise_date: One-third of the shares will vest annually over a three-year period, commencing on the first anniversary date of the grant. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:38 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units · Derivative | 153 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 11 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153 Underlying: Common Stock · 153 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 21:38 UTC |
WIDDER KENNETH JDirector
|
GrantRestricted Stock Units · Derivative | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020498 · doc4.xml · derivative · entry 10 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 512 Underlying: Common Stock · 512 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F5 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.